Quoin Pharmaceuticals Ltd... (QNRX)
NASDAQ: QNRX
· Real-Time Price · USD
7.20
-0.10 (-1.44%)
At close: Oct 03, 2025, 3:59 PM
7.20
0.00%
After-hours: Oct 03, 2025, 05:40 PM EDT
-1.44% (1D)
| Bid | 7.14 |
| Market Cap | 4.23M |
| Revenue (ttm) | 100.37K |
| Net Income (ttm) | -12.17M |
| EPS (ttm) | 951.87 |
| PE Ratio (ttm) | 0.01 |
| Forward PE | -0.47 |
| Analyst | n/a |
| Dividends | n/a |
| Ask | 7.45 |
| Volume | 8,822 |
| Avg. Volume (20D) | 42,614 |
| Open | 7.35 |
| Previous Close | 7.30 |
| Day's Range | 7.14 - 7.38 |
| 52-Week Range | 5.01 - 54.95 |
| Beta | 1.86 |
| Ex-Dividend Date | n/a |
About QNRX
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol QNRX
Website n/a
4 months ago
+0%
QNRX stock has given up its prior gain. Quoin Phar...
Unlock content with
Pro Subscription
4 months ago
+0%
Quoin Pharmaceuticals shares are trading higher after the company announced it received FDA clearance to initiate a second whole-body QRX003 netherton syndrome clinical study.
